Career history of Juergen A. Martens
Former positions of Juergen A. Martens
| Companies | Position | Start | End |
|---|---|---|---|
| NEOS THERAPEUTICS, INC. | Chief Operating Officer | 2016-05-30 | 2017-06-29 |
| Chief Tech/Sci/R&D Officer | 2016-05-30 | 2017-06-29 | |
| MANNKIND CORPORATION | Chief Operating Officer | 2015-01-08 | 2016-03-17 |
| Chief Tech/Sci/R&D Officer | 2005-08-31 | 2014-12-31 | |
| NEKTAR THERAPEUTICS | Chief Tech/Sci/R&D Officer | 1999-12-31 | 2005-07-31 |
Training of Juergen A. Martens
| University of Pennsylvania | Graduate Degree |
| Philipps University of Marburg | Doctorate Degree |
| Mannheim Technical College | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Germany | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Operating Officer | 2 |
| Graduate Degree | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
- Stock Market
- Insiders
- Juergen A. Martens
- Experience
